Skip to content
Screener

Capricor Therapeutics CAPR Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$14.49+10.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.19-1.7%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$9.18-7.0%
Cytokinetics logo
CytokineticsCYTK
-$1.31+57.4%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$4.60+1.9%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$242.07M-31.6%
Enterprise value$151.43M-54.3%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Calculated from Capricor Therapeutics’s reported figures.

Based on the most recent quarter.

The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →

Filed
May 13, 2026, 5:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060382

FAQ

What is Capricor Therapeutics's book value per share?
Capricor Therapeutics (CAPR) reported book value per share of $4.85 in Q1 2026.
How has Capricor Therapeutics's book value per share changed year-over-year?
Capricor Therapeutics's book value per share increased by 73.5% year-over-year, from $2.80 to $4.85.
What is the long-term trend for Capricor Therapeutics's book value per share?
Over 5 years (2020 to 2025), Capricor Therapeutics's book value per share has grown at a 29.4% compound annual growth rate (CAGR), from $1.81 to $6.58.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Capricor Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude